Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Date: June 16, 2015
Pages: 50
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O0B2D1CBB8AEN
Leaflet:

Download PDF Leaflet

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review
Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Osiris Therapeutics, Inc. (Osiris) is a biotechnology company that conducts research, development and commercialization of stem cell products for the treatment of conditions related to wound, orthopedic, and sports medicine. The company operates through its biosurgery business segment develops new products related to diabetic foot ulcers, venous stasis ulcers, dermal burns, and sports medicine products for motion preservation. The product portfolio of the company includes commercialized products, Grafix, Ovation, OvationOS and Cartiform. The company is headquartered in Columbia, Maryland, the US.

Osiris Therapeutics, Inc. Key Recent Developments

May 21, 2015: Osiris Evaluates the Establishment of an International Subsidiary
May 08, 2015: Osiris Therapeutics Announces First Quarter 2015 Financial Results
Apr 30, 2015: Osiris to Present Advanced Research on Chronic Wound Treatment Using Cryopreserved Placental Membranes
Apr 09, 2015: Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., as Chief Scientific Officer
Mar 05, 2015: Osiris Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results: For the Full Year, Revenue Increased 146% and Company Reports Record Revenue in Fourth Quarter

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Osiris Therapeutics, Inc. - Key Facts
Osiris Therapeutics, Inc. - Key Employees
Osiris Therapeutics, Inc. - Key Employee Biographies
Osiris Therapeutics, Inc. - Major Products and Services
Osiris Therapeutics, Inc. - Medical Equipment Pipeline Products Data
Osiris Therapeutics, Inc. Pipeline Products by Equipment Type
Osiris Therapeutics, Inc. Pipeline Products by Development Stage
Osiris Therapeutics, Inc. - History
Osiris Therapeutics, Inc. - Company Statement
Osiris Therapeutics, Inc. - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Osiris Therapeutics, Inc. - Business Description
Osiris Therapeutics, Inc. - Corporate Strategy
Osiris Therapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Osiris Therapeutics, Inc. - Strengths
Strength - Emphasis on Research
Strength - Integration of Operations
Strength - Technology and Manufacturing Process
Osiris Therapeutics, Inc. - Weaknesses
Weakness - History of Losses
Osiris Therapeutics, Inc. - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Global Wound Care Management Market
Opportunity - Diabetic Foot Ulcers: Market Potential
Osiris Therapeutics, Inc. - Threats
Threat - Competitive Landscape
Threat - Rapid Technological Advancements
Threat - Stringent Government Regulation
Osiris Therapeutics, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Osiris Therapeutics, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Osiris Therapeutics, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
Osiris Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Osiris Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Osiris Therapeutics, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 08, 2015: Osiris Therapeutics Announces First Quarter 2015 Financial Results
Apr 09, 2015: Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., as Chief Scientific Officer
Mar 05, 2015: Osiris Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results: For the Full Year, Revenue Increased 146% and Company Reports Record Revenue in Fourth Quarter
Dec 03, 2014: Osiris Therapeutics Announces Expansion of the Leadership Team
Nov 07, 2014: Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable
Oct 16, 2014: Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds
Aug 07, 2014: Osiris Therapeutics Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter
May 12, 2014: Osiris Reports First Quarter 2014 Results: Revenue Up 25% and Gross Margin Improved from 73% to 78%
May 01, 2014: Synthes Chairman Emeritus Hansjorg Wyss Joins Osiris as a Strategic Advisor
Apr 09, 2014: Osiris Announces Receipt of $15 Million Cash Payment for Prochymal

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Osiris Therapeutics, Inc., Key Facts
Osiris Therapeutics, Inc., Key Employees
Osiris Therapeutics, Inc., Key Employee Biographies
Osiris Therapeutics, Inc., Major Products and Services
Osiris Therapeutics, Inc. Number of Pipeline Products by Equipment Type
Osiris Therapeutics, Inc. Pipeline Products by Equipment Type
Osiris Therapeutics, Inc. Number of Pipeline Products by Development Stage
Osiris Therapeutics, Inc. Pipeline Products by Development Stage
Osiris Therapeutics, Inc., History
Osiris Therapeutics, Inc., Key Competitors
Osiris Therapeutics, Inc., Ratios based on current share price
Osiris Therapeutics, Inc., Annual Ratios
Osiris Therapeutics, Inc., Interim Ratios
Osiris Therapeutics, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Osiris Therapeutics, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
Osiris Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Osiris Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Osiris Therapeutics, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Osiris Therapeutics, Inc. Pipeline Products by Equipment Type
Osiris Therapeutics, Inc. Pipeline Products by Development Stage
Osiris Therapeutics, Inc., Performance Chart (2010 - 2014)
Osiris Therapeutics, Inc., Ratio Charts
Osiris Therapeutics, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Osiris Therapeutics, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015
Osiris Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Osiris Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: